Loading clinical trials...
Loading clinical trials...
A Multi-centre, Randomised, Double-blind, Placebo-controlled, Crossover Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma
Conditions
Interventions
GSK2269557 DPI
Placebo DPI
Locations
12
Germany
GSK Investigational Site
Munich, Bavaria, Germany
GSK Investigational Site
Rüdersdorf, Brandenburg, Germany
GSK Investigational Site
Frankfurt am Main, Hesse, Germany
GSK Investigational Site
Frankfurt am Main, Hesse, Germany
GSK Investigational Site
Homburg, Saarland, Germany
GSK Investigational Site
Leipzig, Saxony, Germany
Start Date
October 1, 2015
Primary Completion Date
September 21, 2016
Completion Date
September 28, 2016
Last Updated
August 1, 2018
NCT06712563
NCT07518472
NCT06831994
NCT05730088
NCT02755974
NCT07363980
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions